Vitrivax
UEI: VFTQREMA1CZ4
• CAGE: 8LMB7
Overview
Awardee Type
Parent
Company Description
VitriVax expands global accessibility and utility of vaccines with its innovative platform creating thermostable, single shot vaccines for a range of compounds.
Keywords
Vaccine formulation
Name
Vitrivax
Website
Headquarters
Boulder, CO
United States
United States
Most Recent Award
Jan. 12, 2023
Calculating
Federal contract recipient
VITRIVAX, INC.
dba VITRIVAX INC
(UEI VFTQREMA1CZ4, CAGE 8LMB7)
is headquartered in Boulder CO.
Its primary registered NAICS is 541714 Research and Development in Biotechnology (except Nanobiotechnology).
The corporation
was founded in October 2014 and
federally registered in
February 2022.
Federal Award Analysis
Vitrivax federal award history
$-
Contracts
$-
Subcontracts
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
VITRIVAX, INC.
DBA
VITRIVAX INC
UEI
VFTQREMA1CZ4
CAGE Code
8LMB7
SBA Certifications
None
Self Certifications
Self-Certified Small Disadvantaged Business
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
Oct. 15, 2014
Initial Registration
Feb. 10, 2022
Last Registration
March 12, 2025
Registration Activation
March 12, 2025
Registration Expiration
March 10, 2026
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
State of Incorporation
DE
Country of Incorporation
USA
Employees
<500
Accepts Credit Cards
No
People
Vendor contacts at Vitrivax
Contract Awards
Vitrivax prime contract awards
Teaming Partners
Disclosed awardee sub and prime contract and grant relationships
Vitrivax